Pharmaceutical Lactose Market
Market Insights on Pharmaceutical Lactose covering sales outlook, demand forecast & up-to-date key trends
Pharmaceutical Lactose Market By Product Type (Beta-Lactose, Gamma-Lactose monohydrate, Amorphous lactose, Spray dried lactose) & Region - Forecast to 2021 - 2031
About the Pharmaceutical Lactose Report
Increased access to medication through generic drug production, development of new treatments for chronic diseases, increasing research and development spending, rising competition, and advent of new technologies are driving the pharmaceutical lactose market.
The ability to perform various functions such as modifying drug release, taste masking accelerates, and improving active pharmaceutical ingredient stability are the major factors fuelling the for demand of pharmaceutical lactose. In addition to this, increasing adoption of excipients to enhance drug solubility and improve bioavailability has amped up the demand for pharmaceutical lactose.
In its new study, consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for pharmaceutical lactose market. The report tracks the global sales of pharmaceutical lactose market in 20+ high-growth markets. This report gives details of the prospective growing markets in the gummy vitamins market and what are the driving factors of the pharmaceutical lactose market.
Let us know your requirement to get
100% FREE customization
How the Historical and Future Outlook of Pharmaceutical Lactose Market Compare?
Rising preference toward preventive healthcare globally is anticipated to increase the demand for pharmaceutical lactose over the forecast period. Rising investments by local and foreign players in the pharmaceutical manufacturing sector, specifically in developing economies such as Brazil and China is anticipated to have a positive influence on pharmaceutical lactose industry growth.
In the past few years the awareness regarding functions and health benefits associated with pharmaceutical lactose has increased across the globe, leading to the influx of new players. Key producers are focusing on launching innovative products as well as focusing on partnerships to increase the production capacity.
According to FMI’s analysis, pharmaceutical lactose market have grown at 3.5% CAGR between 2016 and 2020.
Inhalation lactose is an excipient of high functionality that is helpful for the consistent performance of dry powder inhalation and thus ultimately to the patient’s wellbeing. Key players, end users, suppliers and regulators are working deeply to understand the inhalation lactose benefits and to adopt a various manufacturing strategy based on statistical models and to provide precise regulatory framework for advancement in forecast period. The significance of inhalation lactose in DPI performance has attracted a great deal of regulatory attention and the inhalation lactose remains an attraction in the global pharmaceutical lactose market.
The aim for improving palatability in oral drugs have driven the growth of various formulations with improved acceptability and performance. In recent years, mouth dissolving tablets have received important demand, and the field has become a rapidly growing area in the pharmaceutical industry. By numerous conventional methods, such as wet granulation, molding, direct compression, spray drying, sublimation and freeze drying etc. mouth dissolving tablets can be prepared
Will Use Of 3D Models Enhance Precision In Pharmaceutical Lactose?
In the pharmaceutical industry it is possible to design and manufacture novel complex drug products by using advent of 3D printing technology. 3D printing allows the creation of reliable dosage forms for clinical use and offers the capability to tailor doses for specific users.
To embrace new opportunities, pharmaceutical lactose manufacturers are adopting 3D technology for developing lactose blends with sufficient flow, wetting and binding. Benefits such as early phase drug development, high dose flexibility, and enabling personalized medicine escalate the usage of 3D printing in pharmaceutical industry.
About 1% of the drugs that are investigated make it through testing and gain approval. However, new technology is being pursued which accommodates increased precision in drug discovery. The advantage of 3D models is that it permits higher predictability of toxicity and effectiveness of a particular drug before it moves into the clinical trial phase, which in turn can reduce the attrition rate of new drugs and also speed up the new drug discovery process.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWill Innovation In Drug Delivery Drive Pharmaceutical Lactose Market?
The advent of new treatments will create interest in unique forms of drug delivery. The trend of new biological treatments is expected to continue through 2021. With the growing demand for higher health standards across the globe, there is increasing realization that the treatment of moderate conditions using conventional patient centric dosages presents a lucrative market. Specifically in the niche area of topicals, with the new guidelines and changes in the industry, the requirement for consistent production of complex semi solids can be anticipated to grow.
Country-wise Insights
Why Spain is leading the Europe Pharmaceutical Lactose Market?
Spain is leading the Europe pharmaceutical lactose market. Government support for hospitality services and development of treatment molecules and drugs in the country is an important factor driving pharmaceutical lactose market in Spain. Private insurance sector and medic aim in Spain is active with support to the patients with financial aids for several disease treatment this will push the pharmaceutical lactose market in Spain.
What is Driving Pharmaceutical Lactose Sales in Mexico?
Mexico is expected to continue at its leading position in forecast period with estimated market share of 23.2% by end of 2031. Latin America has a relatively smaller market share for healthcare and pharmaceutical and is slowly moving up the pharmaceutical sector growth ladder with a focus on innovation and adoption of advanced technologies across numerous industries.
Mexico is a rapidly growing hub for medical technology in Latin America. It has been attracting foreign investments in the Latin America. Increased penetration of leading pharmaceutical companies and adoption of new oral drug technologies in Mexico is anticipated to drive pharmaceutical lactose market in the country.
Will India’s Pharmaceutical Lactose Market Grow Exponentially?
The India market is expected to rise at the fastest CAGR in South Asia pharmaceutical lactose market. India is anticipated to grow with CAGR 6.9% in forecast period. Increasing research and development by regional as well as international players in India is projected to push the healthcare industry results in boost to pharmaceutical lactose market in the country.
South Asian countries showcase lower price range for drugs as compared to other regions. Increasing average dollar spending by India and ASEAN countries is escalating demand of the drugs resulting in growth of pharmaceutical lactose market across the region.
Why is Demand for Pharmaceutical Lactose Is Growing in China?
China’s pharmaceutical lactose market is anticipated to grow at a CAGR of little below 6% through 2031. China’s initiatives such as streamlining its state-owned enterprise (SOE) sector and introducing new amendments to current foreign investment laws will go a long way in ensuring enhanced economic stability in the country. The adoption of new technologies and increased penetration of the biological tools along with increasing research and development funds in China are expected to drive the market for pharmaceutical lactose during the forecast period.
Why is U.S. leading North America Pharmaceutical Lactose Market?
The U.S. is dominating the pharmaceutical lactose market in North America with market share of 60.6% in 2021. The increasing product adoption and presence of a well-established pharmaceutical industry are the major reasons for driving pharmaceutical lactose market in U.S. Continuous updates and technological advancements in the customized biologicals and advanced drugs are current trends in the regional market.
Category Wise
Why Α-Lactose Monohydrate Is The Top-Selling Product?
α-Lactose monohydrate is leading in terms of product type in the pharmaceutical lactose market with market share nearly 46% in 2021. The segment is expected to show significant growth in forecast period. In the pharmaceutical industry this type of lactose is used widely as an excipient in the production of solid dosage forms. In dry powder inhalers it is used as a carrier. The pharmaceutical products in which α-Lactose monohydrate used as a primary ingredient have higher shelf life as compared to other products in which rest of pharmaceutical lactose types used.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape for Pharmaceutical Lactose Market
The global pharmaceutical lactose market is witnessing a rise in competition as more and more market players belonging to the lactose industry are taking an interest in venturing in this B2B business model. The rising demand for pharmaceutical lactose is creating tremendous opportunities for market players manufacturing pharmaceutical lactose.
Due to rising competition in the pharmaceutical lactose market, key players are focusing on launching innovative new products of pharmaceutical lactose in the market to sustain the position in the pharmaceutical lactose market.
For instance-
- In 2015, Meggle launched triple compound pharma grade lactose CombiLac®, specifically designed to ease oral solid dosage
The key players of pharmaceutical lactose are focusing on partnership and joint venture to expand their product portfolio as well as to strengthen their supply chain. The partnership help to increase the production capacity of pharmaceutical lactose as well as expand the geographical reach.
For instance-
- In Aug 2020, Armor Pharma signed a partnership with Nordmann for expanding its product footprint. Nordmann, an international chemical distributor, is supplying the German market with pharmaceutical-grade lactose products from the French manufacturer Armor Pharma.
Some of the leading companies operating in the pharmaceutical lactose market are:
- Ba'emek Advanced Technologies Ltd (Tnuva Group)
- Hilmar Ingredients
- Armor Pharma
- Avantor, Inc.
- Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
- Lactose (India) Limited
- DFE Pharma
- Hoogwegt Groep B.V.
- Merck KgaA
- Kerry plc
- Milei GmbH
- BASF SE
- MEGGLE Excipients & Technology
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Pharmaceutical Lactose Report
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Pharmaceutical Lactose Market Analysis |
USD Million for value and Metric Tons for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Chile, Peru, Argentina, Rest of Latin America, Germany, France, Italy, U.K., Spain, BENELUX, Nordic, Poland, Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Singapore, Indonesia, Thailand, Rest of South Asia, Australia, New Zealand, GCC Countries, South Africa, Turkey, North Africa, Central Africa, Rest of MEA |
|
Key Segments Covered |
Product Type |
|
Key Companies Profiled |
|
|
Pharmaceutical Lactose Report Coverage |
Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Pharmaceutical Lactose Market by Category
Product Type
- Β-Lactose
- α-Lactose monohydrate
- Amorphous lactose
- Spray dried lactose
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa (MEA)
- Oceania
Frequently Asked Questions
The South Asia market is expected to grow at above 6% CAGR in pharmaceutical lactose market during forecast period. Presence of several leading players and higher spending on drugs among consumers will enable growth in the market.
α-Lactose monohydrate is anticipated to continue dominating the pharmaceutical lactose market in terms of product through 2031. The demand for excipients is rising rapidly across the globe, α-Lactose monohydrate is primary ingredient in excipients due to which its use is further expected to rise in near future.
Some of the key players operating in the pharmaceutical lactose market are Avantor, Inc., Ba'emek Advanced Technologies Ltd (Tnuva Group), Koninklijke FrieslandCampina N.V., Armor Pharma, Hilmar Ingredients Inc., Hoogwegt Groep B.V., Kerry Group plc, Lactose (India) Limited, Merck KGaA, BASF SE, Milei GmbH, and other playes.
Key players in the pharmaceutical lactose market are focusing on launching high quality lactose products. Globally the number of new players entering in the market are growing due to which, completion is getting intense in the pharmaceutical lactose market.
Cloud-based technologies are being incorporated in the development of pharmaceutical lactose. Continuous developments in cloud-based drug discovery platforms are anticipated to contribute significantly towards the growth of the global market for pharmaceutical lactose.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Positioning Metrics
4.2. Product Utilization in High-Growth End Use Applications
4.3. Quality Certifications and Claims Impact Analysis
5. Global Pharmaceutical Lactose Market Demand Analysis 2016-2020 and Forecast, 2021-2031
5.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020
5.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031
5.3. Y-o-Y Growth Trend Analysis
6. Global Pharmaceutical Lactose Market - Pricing Analysis
6.1. Regional Pricing Analysis (US$/Metric Tons) By Product
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Pharmaceutical Lactose Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Policy Developments and Regulatory Scenario
8.2. Supply/Demand and Trade Scenario
8.3. Nutritional Composition of Pharmaceutical Lactose
8.4. Macro-Economic Factors
8.4.1. Global GDP Growth Outlook
8.4.2. Global Industry Value Added
8.5. Forecast Factors - Relevance & Impact
8.5.1. Dairy Production Outlook
8.5.2. Trade Tariffs and Regulation Outlook
8.5.3. Production/Processing Capacity Growth
8.5.4. Pharmaceutical Industry Outlook
8.6. Value Chain Analysis
8.6.1. % of Profit margin Analysis
8.6.2. List of Active Market Participants
8.6.2.1. Raw Material Suppliers
8.6.2.2. Product Manufacturers
8.6.2.3. End Users
8.7. Market Dynamics
8.7.1. Drivers
8.7.2. Restraints
8.7.3. Opportunity
9. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2016-2020
9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2021-2031
9.3.1. Β-Lactose
9.3.2. α-Lactose monohydrate
9.3.3. Amorphous lactose
9.3.4. Spray dried lactose
9.4. Market Attractiveness Analysis By Product Type
10. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Application
10.1. Introduction / Key Findings
10.2. % of Demand Assessment
10.2.1. Direct Compression
10.2.2. Wet Granulation
10.2.3. Dry Granulation
10.2.4. Powder Preparations
10.2.5. Dry Powder Inhalation
10.2.6. Others
10.3. Market Attractiveness Analysis By Application
11. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016-2020
11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis By Region
12. North America Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.2. By Product Type
12.5. Market Share Analysis By Country, 2021
12.5.1. U.S.
12.5.1.1. By Product Type
12.5.2. Canada
12.5.2.1. By Product Type
12.6. Market Attractiveness Analysis
12.6.1. By Country
12.6.2. By Product Type
12.7. Market Trends
12.8. Key Market Participants - Intensity Mapping
12.9. Drivers and Restraints - Impact Analysis
13. Latin America Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Argentina
13.4.1.4. Chile
13.4.1.5. Peru
13.4.1.6. Rest of Latin America
13.4.2. By Product Type
13.5. Market Share Analysis By Country, 2021
13.5.1. Brazil
13.5.1.1. By Product Type
13.5.2. Mexico
13.5.2.1. By Product Type
13.5.3. Argentina
13.5.3.1. By Product Type
13.5.4. Chile
13.5.4.1. By Product Type
13.5.5. Peru
13.5.5.1. By Product Type
13.6. Market Attractiveness Analysis
13.6.1. By Country
13.6.2. By Product Type
13.7. Market Trends
13.8. Key Market Participants - Intensity Mapping
13.9. Drivers and Restraints - Impact Analysis
14. Europe Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. Italy
14.4.1.3. France
14.4.1.4. U.K.
14.4.1.5. Spain
14.4.1.6. Russia
14.4.1.7. Poland
14.4.1.8. BENELUX
14.4.1.9. Nordic
14.4.1.10. Rest of Europe
14.4.2. By Product Type
14.5. Market Share Analysis By Country, 2021
14.5.1. Germany
14.5.1.1. By Product Type
14.5.2. Italy
14.5.2.1. By Product Type
14.5.3. France
14.5.3.1. By Product Type
14.5.4. U.K.
14.5.4.1. By Product Type
14.5.5. Spain
14.5.5.1. By Product Type
14.5.6. Russia
14.5.6.1. By Product Type
14.5.7. Poland
14.5.7.1. By Product Type
14.5.8. BENELUX
14.5.8.1. By Product Type
14.5.9. Nordic
14.5.9.1. By Product Type
14.6. Market Attractiveness Analysis
14.6.1. By Country
14.6.2. By Product Type
14.7. Market Trends
14.8. Key Market Participants - Intensity Mapping
14.9. Drivers and Restraints - Impact Analysis
15. East Asia Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.2. By Product Type
15.5. Market Share Analysis By Country, 2021
15.5.1. China
15.5.1.1. By Product Type
15.5.2. Japan
15.5.2.1. By Product Type
15.5.3. South Korea
15.5.3.1. By Product Type
15.6. Market Attractiveness Analysis
15.6.1. By Country
15.6.2. By Product Type
15.7. Market Trends
15.8. Key Market Participants - Intensity Mapping
15.9. Drivers and Restraints - Impact Analysis
16. South Asia Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
16.4.1. By Country
16.4.1.1. India
16.4.1.2. Thailand
16.4.1.3. Indonesia
16.4.1.4. Malaysia
16.4.1.5. Singapore
16.4.1.6. Rest of South Asia
16.4.2. By Product Type
16.5. Market Share Analysis By Country, 2021
16.5.1. India
16.5.1.1. By Product Type
16.5.2. Thailand
16.5.2.1. By Product Type
16.5.3. Indonesia
16.5.3.1. By Product Type
16.5.4. Malaysia
16.5.4.1. By Product Type
16.5.5. Singapore
16.5.5.1. By Product Type
16.6. Market Attractiveness Analysis
16.6.1. By Country
16.6.2. By Product Type
16.7. Market Trends
16.8. Key Market Participants - Intensity Mapping
16.9. Drivers and Restraints - Impact Analysis
17. Oceania Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
17.4.1. By Country
17.4.1.1. Australia
17.4.1.2. New Zealand
17.4.2. By Product Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020
18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031
18.4.1. By Country
18.4.1.1. South Africa
18.4.1.2. GCC Countries
18.4.1.3. North Africa
18.4.1.4. Central Africa
18.4.1.5. Rest of Middle East and Africa
18.4.2. By Product Type
18.5. Market Share Analysis By Country, 2021
18.5.1. South Africa
18.5.1.1. By Product Type
18.5.2. GCC Countries
18.5.2.1. By Product Type
18.5.3. North Africa
18.5.3.1. By Product Type
18.5.4. Central Africa
18.5.4.1. By Product Type
18.6. Market Attractiveness Analysis
18.6.1. By Country
18.6.2. By Product Type
18.7. Market Trends
18.8. Key Market Participants - Intensity Mapping
18.9. Drivers and Restraints - Impact Analysis
19. Emerging Countries Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Growth Comparison of Global Market v/s Emerging Countries
19.2. China Pharmaceutical Lactose Market Analysis
19.2.1. Introduction
19.2.2. Pricing Analysis
19.2.3. PEST Analysis
19.2.4. Market Value Proportion Analysis by Market Taxonomy
19.2.5. Market Volume (Metric Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.2.5.1. By Product Type
19.2.6. China Pharmaceutical Lactose Market - Competition Landscape
19.2.7. China - Trade Analysis
19.3. India Pharmaceutical Lactose Market Analysis
19.3.1. Introduction
19.3.2. Pricing Analysis
19.3.3. PEST Analysis
19.3.4. Market Value Proportion Analysis by Market Taxonomy
19.3.5. Market Volume (Metric Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
19.3.5.1. By Product Type
19.3.6. India Pharmaceutical Lactose Market - Competition Landscape
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Company Share Analysis of Top Players
20.2.1. By Product Type
20.2.2. By Region
20.3. Market Presence Analysis
20.3.1. By Regional Footprint of Players
20.3.2. Product Footprint by Players
20.3.3. Channel Footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep pe (Tentative List)
21.2.1. Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product/Region)
21.2.1.4. Sales Footprint
21.2.1.5. Strategy Overview
21.2.2. Armor Pharma
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product/Region)
21.2.2.4. Sales Footprint
21.2.2.5. Strategy Overview
21.2.3. Avantor, Inc.
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product/Region)
21.2.3.4. Sales Footprint
21.2.3.5. Strategy Overview
21.2.4. Ba'emek Advanced Technologies Ltd (Tnuva Group)
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product/Region)
21.2.4.4. Sales Footprint
21.2.4.5. Strategy Overview
21.2.5. BASF SE
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product/Region)
21.2.5.4. Sales Footprint
21.2.5.5. Strategy Overview
21.2.6. DFE Pharma (JV of Royal FrieslandCampina & Fonterra Ltd.)
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product/Region)
21.2.6.4. Sales Footprint
21.2.6.5. Strategy Overview
21.2.7. Hilmar Ingredients
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product/Region)
21.2.7.4. Sales Footprint
21.2.7.5. Strategy Overview
21.2.8. Hoogwegt Groep B.V.
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product/Region)
21.2.8.4. Sales Footprint
21.2.8.5. Strategy Overview
21.2.9. Kerry plc
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product/Region)
21.2.9.4. Sales Footprint
21.2.9.5. Strategy Overview
21.2.10. Lactose (India) Limited
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product/Region)
21.2.10.4. Sales Footprint
21.2.10.5. Strategy Overview
21.2.11. Merck KgaA
21.2.11.1. Overview
21.2.11.2. Product Portfolio
21.2.11.3. Profitability by Market Segments (Product/Region)
21.2.11.4. Sales Footprint
21.2.11.5. Strategy Overview
21.2.12. Milei GmbH
21.2.12.1. Overview
21.2.12.2. Product Portfolio
21.2.12.3. Profitability by Market Segments (Product/Region)
21.2.12.4. Sales Footprint
21.2.12.5. Strategy Overview
21.2.13. MEGGLE Excipients & Technology
21.2.13.1. Overview
21.2.13.2. Product Portfolio
21.2.13.3. Profitability by Market Segments (Product/Region)
21.2.13.4. Sales Footprint
21.2.13.5. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 02: Global Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 03: Global Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 04: Global Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 05: Global Pharmaceutical Lactose Historical Market Value (US$ Mn) by Region, 2016–2020
Table 06: Global Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Region, 2021–2031
Table 07: Global Pharmaceutical Lactose Historical Market Volume (Units) by Region, 2016–2020
Table 08: Global Pharmaceutical Lactose Forecast Market Volume (Units) by Region, 2021–2031
Table 09: North America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 010: North America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 11: North America Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 12: North America Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 13: North America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 14: North America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 15: North America Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 16: North America Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 17: Latin America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 18: Latin America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 19: Latin America Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 20: Latin America Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 21: Latin America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 22: Latin America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 23: Latin America Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 24: Latin America Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 25: Europe Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 26: Europe Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 27: Europe Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 28: Europe Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 29: Europe Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 30: Europe Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 31: Europe Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 32: Europe Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 33: East Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 34: East Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 35: East Asia Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 36: East Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 37: East Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 38: East Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 39: East Asia Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 40: East Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 41: South Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 42: South Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 43: South Asia Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 44: South Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 45: South Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 46: South Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 47: South Asia Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 48: South Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 49: Oceania Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 50: Oceania Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 51: Oceania Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 52: Oceania Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 53: Oceania Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 54: Oceania Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 55: Oceania Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 56: Oceania Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Table 57: Middle East & Africa Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020
Table 58: Middle East & Africa Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031
Table 59: Middle East & Africa Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020
Table 60: Middle East & Africa Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031
Table 61: Middle East & Africa Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020
Table 62: Middle East & Africa Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030
Table 63: Middle East & Africa Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020
Table 64: Middle East & Africa Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 02: Global Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 03: Global Pharmaceutical Lactose Market by Β-Lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031
Figure 04: Global Pharmaceutical Lactose Market by Β-Lactose Incremental $ Opportunity, 2020-2031
Figure 05: Global Pharmaceutical Lactose Market By α-Lactose monohydrate Value (US$ Mn), Volume (MT) and Forecast
Figure 06: Global Pharmaceutical Lactose Market By α-Lactose monohydrate Incremental $ Opportunity, 2020-2031
Figure 07: Global Pharmaceutical Lactose Market by Amorphous lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031
Figure 08: Global Pharmaceutical Lactose Market by Amorphous Lactose Incremental $ Opportunity, 2020-2031
Figure 09: Global Pharmaceutical Lactose Market by Spray dried lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031
Figure 10: Global Pharmaceutical Lactose Market by Spray dried lactose Incremental $ Opportunity, 2020-2031
Figure 11: Global Pharmaceutical Lactose Market Value Share (%) and BPS Analysis by Region, 2021 & 2031
Figure 12: Global Pharmaceutical Lactose Market Y-o-Y Growth (%) Projections by Segment, 2021-2031
Figure 13: North America Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 14: Latin America Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 15: Europe Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 16: East Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 17: South Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 18: Oceania Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 19: Middle East & Africa Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 20: Global Pharmaceutical Lactose Market Attractiveness Analysis by Region, 2021-2031
Figure 21: North America Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 22: North America Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 23: North America Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 24: U.S. Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 25: Canada Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 26: US Market Share Analysis by Product Type, 2021
Figure 27: Canada Market Share Analysis by Product Type, 2021
Figure 28: North America Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 29: North America Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 30: Latin America Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 31: Latin America Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 32: Latin America Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 33: Brazil Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 34: Mexico Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 35: Chile Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 36: Peru Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 37: Argentina Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 38: Rest of LATAM Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 39: Brazil Market Share Analysis by Product Type, 2021
Figure 40: Mexico Market Share Analysis by Product Type, 2021
Figure 41: Argentina Market Share Analysis by Product Type, 2021
Figure 42: Chile Market Share Analysis by Product Type, 2021
Figure 43: Peru Market Share Analysis by Product Type, 2021
Figure 44: Latin America Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 45: Latin America Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 46: Europe Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 47: Europe Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 48: Europe Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 49: Poland Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 50: Germany Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 51: Italy Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 52: Spain Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 53: France Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 54: UK Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 55: BENELUX Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 56: Nordic Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 57: Russia Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 58: Rest of Europe Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 59: Poland Market Share Analysis by Product Type, 2021
Figure 60: Germany Market Share Analysis by Product Type, 2021
Figure 61: Italy Market Share Analysis by Product Type, 2021
Figure 62: Spain Market Share Analysis by Product Type, 2021
Figure 63: France Market Share Analysis by Product Type, 2021
Figure 64: UK Market Share Analysis by Product Type, 2021
Figure 65: BENELUX Market Share Analysis by Product Type, 2021
Figure 66: Nordic Market Share Analysis by Product Type, 2021
Figure 67: Russia Market Share Analysis by Product Type, 2021
Figure 68: Rest of Europe Market Share Analysis by Product Type, 2021
Figure 69: Europe Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 70: Europe Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 71: East Asia Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 72: East Asia Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 73: East Asia Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 74: China Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 75: Japan Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 76: South Korea Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 77: China Market Share Analysis by Product Type, 2021
Figure 78: Japan Market Share Analysis by Product Type, 2021
Figure 79: South Korea Market Share Analysis by Product Type, 2021
Figure 80: East Asia Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 81: East Asia Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 82: South Asia Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 83: South Asia Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 84: South Asia Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 85: Indonesia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 86: Malaysia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 87: Singapore Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 88: India Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 89: Thailand Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 90: Rest of South Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031
Figure 91: Indonesia Market Share Analysis by Product Type, 2021
Figure 92: Malaysia Market Share Analysis by Product Type, 2021
Figure 93: Singapore Market Share Analysis by Product Type, 2021
Figure 94: India Market Share Analysis by Product Type, 2021
Figure 95: Thailand Market Share Analysis by Product Type, 2021
Figure 96: South Asia Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 97: South Asia Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 98: Oceania Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 99: Oceania Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 100: Oceania Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Figure 101: Australia Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 102: New Zealand Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031
Figure 103: Australia Market Share Analysis by Product Type, 2021
Figure 104: New Zealand Market Share Analysis by Product Type, 2021
Figure 105: Oceania Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031
Figure 106: Oceania Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031
Figure 107: MEA Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031
Figure 108: MEA Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031
Figure 109: MEA Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031
Need specific information?
Request CustomizationExplore Food and Beverage Insights
View Reports
